Study | Citrate | Heparin | ||||
---|---|---|---|---|---|---|
Events | Catheter days | Events/1000 catheter days | Events | Catheter days | Events/1000 catheter days | |
Mortality | ||||||
Power | 5 | 19008 | 0.26 | 5 | 17100 | 0.29 |
Weijmer | 13 | 8181 | 1.59 | 18 | 8049 | 2.24 |
MacRae | 4 | 2272 | 1.76 | 5 | 1818 | 2.75 |
Bacteremia | ||||||
Power | 13 | 19008 | 0.68 | 12 | 17100 | 0.70 |
Weijmer | 9 | 8181 | 1.10 | 33 | 8049 | 4.10 |
MacRae | 5 | 2272 | 2.20 | 6 | 1818 | 3.30 |
Access-related hospitalization | ||||||
Power | 17 | 19008 | 0.89 | 12 | 17100 | 0.70 |
Weijmer | 6 | 8181 | 0.70 | 21 | 8049 | 2.70 |
Catheter replacement | ||||||
Buturovic | 1 | 2272 | 1.96 | 1 | 1818 | 4.35 |
MacRae | 8 | 2272 | 3.52 | 5 | 1818 | 2.75 |
Weijmer | 27 | 8181 | 3.21 | 29 | 8049 | 3.56 |
Thrombolysis | ||||||
MacRae | 13 | 2272 | 5.72 | 13 | 1818 | 7.15 |
Power | 1 | 19008 | 0.06 | 1 | 17100 | 0.04 |
Weijmer | 69 | 8181 | 8.28 | 63 | 8049 | 7.88 |
Bleeding | ||||||
MacRae | 25 | 2272 | 11.00 | 37 | 1818 | 20.35 |
Weijmer | 5 | 8181 | 0.60 | 16 | 8049 | 2.00 |